Crossmark

Cladribine and medium-dose cytarabine intensified busulfan plus cyclophosphamide conditioning regimen for adults high-risk B-cell acute lymphoblastic leukemia

Crossref DOI link: https://doi.org/10.1007/s00277-025-06471-2

Published Online: 2025-07-11

Published Print: 2025-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Tingting

Peng, Jie

Liu, Yi

Yang, Shuanghui

Chen, Yan

Xu, Yajing
License Information

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-07-11
More Information

Article History

Received: 17 January 2025

Accepted: 13 June 2025

First Online: 11 July 2025

Declarations

:

: The study was approved by the Ethics Committee of Xiangya Hospital, Central South University, and informed consent was waived.

: N/A.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below